RESUMEN
PURPOSE: Neutrophil-lymphocyte ratio (NLR) is reportedly an effective prognostic tool across various medical and surgical fields, but its value in spinal surgery is unestablished. We aim to investigate the relationship between elevated baseline/postoperative NLR and patient outcomes in spinal surgery. MATERIALS AND METHODS: We performed a systematic search in PubMed, EMBASE, and SCOPUS databases for studies investigating the prognostic value of NLR in spine patients.Odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CIs) were analysed on the RevMan 5.4 software. Where meta-analysis was not possible, we vote-counted the direction of the effect of elevated NLR. The GRADE framework for prognostic factor research was utilised to assess the certainty of the evidence for each outcome measure. RESULTS: Five outcome measures (overall survival, mortality, disease-free survival, functional recovery and complications) were assessed across 16 studies involving 5471 patients. Elevated baseline NLR was associated with reduced overall survival (HR: 1.63, 95 % CI: 1.05 - 2.54) (GRADE: low) and worsened functional recovery (OR: 0.93, 95 % CI: 0.87 - 0.98) (GRADE: low). There was no association between baseline NLR and disease-free survival (HR: 2.42, 95 % CI: 0.49 - 11.83) (GRADE: very low) or mortality (OR: 1.39, 95 % CI: 0.41 - 4.75) (GRADE: very low). Elevated NLR levels measured on days 3-4 and days 6-7 postoperatively, but not NLR measured at baseline or on days 1-2 postoperatively, were associated with greater risks of complications (GRADE: low). CONCLUSIONS: NLR is an objective tool with the potential to identify the patients that would benefit from surgery and facilitate shared decision-making.
Asunto(s)
Linfocitos , Neutrófilos , Columna Vertebral , Humanos , Supervivencia sin Enfermedad , Recuento de Linfocitos , Pronóstico , Columna Vertebral/cirugíaRESUMEN
Background: Hearing is necessary for speech and language development, children with bilateral hearing loss often have impaired speech and language abilities thus limiting educational attainment. Early detection and intervention will help minimize such effects. Therefore, neonatal hearing screening program has been advocated in developing countries. Objective: TThe objective of this study is to determine the prevalence of hearing loss and risk factors among full-term inborn neonates delivered in a University Teaching Hospital with transient evoked otoacoustic emission (TEOAE). Materials and Methods: All full-term neonates delivered in a University Teaching Hospital were included in this prospective cross-sectional study. The hospital's ethical committee gave approval. The researcher obtained informed consent from the parents and administered a questionnaire for demographic, prenatal, and postnatal data. A comprehensive head and neck examination preceded the preliminary otoscopy. With the help of a hand-held otodynamic otoport, Neonatal Hearing Screening Program otoacoustic emission (OAE), each ear's hearing was assessed. Statistical Product and Service Solutions (SPSS) version 22.0 was used to analyse the data. Results: 150 full-term neonates were screened, of which 72 (48%) were males and 78 (52%) were females. Neonates that failed the TEOAE in both ears were 12 (8%). 18 (12%) neonates had a refer in right ear only, while 24 (16%) had a refer in the left ear only. The only significant risk factor with a referral outcome of TEOAE was family history of childhood hearing loss (23.1%). Conclusion: This study found a high prevalence (8%) of failed TEOAE of full-term neonates delivered in our hospital with a significant risk factor of family history of childhood hearing loss.
RESUMEN
BACKGROUND: In the United States of America (USA), cannabis is legal in 28 states for medical purposes and 8 states for recreational use. In 2016, the legal marijuana industry reached nearly $7 billion in sales in the USA alone. Although consumption continues to increase, the medical effects of marijuana remain understudied. Young males comprise the demographic most likely to consume cannabis, and these individuals will be most vulnerable to its short- and long-term consequences. OBJECTIVE: The purpose of this manuscript is to systematically review the available literature describing the effects of marijuana on male infertility, sexual health, and urologic neoplasms. MATERIALS AND METHODS: A comprehensive literature search was conducted using the Medline and Embase databases through May 2017. In vitro models, animal models, case series, case-control, and cohort designs were included. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement was utilized to report results. RESULTS: After exclusions, 91 articles were synthesized for qualitative analysis. Of these manuscripts, 30 pertained to marijuana and male infertility, 36 discussed cannabis and male sexual health/hormones, and 25 explored the relationship between marijuana and urologic neoplasms. DISCUSSION: With respect to male factor fertility using semen parameters as a surrogate, cannabinoids likely play an inhibitory role. Data on marijuana and male sexual function are mixed but suggest that marijuana may enhance the subjective experience of sexual intercourse while potentially contributing to ED in a dose-dependent manner. Cannabis has been associated with both increased and decreased risk of malignancy depending upon the target organ. Marijuana exposure seems to be an independent risk factor for testis cancer, data on bladder cancer are conflicting, and the evidence on prostate cancer supports anti-neoplastic effects of cannabinoids. CONCLUSION: Studies of the effects of cannabis suggest impact on urologic health and disease. Prospective, long-term studies are necessary for further elucidation of these effects.
Asunto(s)
Cannabis/efectos adversos , Genitales Masculinos/efectos de los fármacos , Infertilidad Masculina/etiología , Neoplasias Urológicas/patología , Humanos , Infertilidad Masculina/epidemiología , Masculino , Neoplasias Urológicas/epidemiología , Neoplasias Urológicas/etiologíaRESUMEN
UNLABELLED: Renal cell carcinoma (RCC) propagates into the IVC in 4% of cases with 1% extending into the right atrium. Radical surgical resection remains the definitive curative/palliative treatment in those without significant metastases. The aim was to review our experience in patients with different levels of IVC involvement, cardiopulmonary bypass (CPB) and perioperative/long term outcomes. PATIENTS AND METHODS: From 2001 to 2012, 24 radical nephrectomies with IVC thrombectomy were performed. A retrospective chart review was undertaken to record demographics, presenting symptoms, duration of surgery, peri-operative transfusion, CPB and peri-operative complications, tumour grade/stage, and patient survival. RESULTS: We identified 24 patients (18 male, Age median 59 range 35-78). The commonest presenting symptoms were weight loss, pain and haematuria. The majority of tumours were right sided (n = 17) with 8 having lung metastases at presentation. Thrombus level was 16 (infradiaphragmatic), 2 (supradiaphragmatic), 6 (intra-atrial). 15 patients required sternotomy for vascular control and 9 required CPB both with a significantly longer operative time compared (6.1 ± 3.5 vs. 7.2 ± 1.2 vs. 3.5 ± 1.1 h, respectively). Peri-operative complications (n = 21) included cardiopulmonary, renal, gastrointestinal and septic problems. There were 2 peri-operative deaths. Blood transfusion was significantly less in those not requiring sternotomy or CPB using the "Cell Saver" device. The majority were Fuhrman grade 3 (n = 16) and clear cell type (n = 14). Overall 3-year survival was 100% (Laparotomy only), 40% (sternotomy + cross-clamp), and 20% (CPB). CONCLUSIONS: IVC thrombectomy has significant morbidity and requires careful patient selection and a multi-disciplinary approach to optimise patient outcomes. In this series, the level of IVC thrombus and requirement for CPB directly affects patient morbidity and outcome.
Asunto(s)
Carcinoma de Células Renales/cirugía , Atrios Cardíacos , Cardiopatías/etiología , Neoplasias Renales/cirugía , Trombectomía/métodos , Trombosis/etiología , Vena Cava Inferior , Adulto , Anciano , Carcinoma de Células Renales/complicaciones , Carcinoma de Células Renales/diagnóstico , Puente Cardiopulmonar/métodos , Femenino , Estudios de Seguimiento , Predicción , Cardiopatías/diagnóstico , Cardiopatías/cirugía , Humanos , Neoplasias Renales/complicaciones , Neoplasias Renales/diagnóstico , Masculino , Persona de Mediana Edad , Células Neoplásicas Circulantes/patología , Nefrectomía , Selección de Paciente , Estudios Retrospectivos , Trombosis/diagnóstico , Trombosis/cirugía , Resultado del TratamientoRESUMEN
AIMS: Myotonic dystrophy types 1 and 2 (DM1 and DM2) are multisystem disorders caused by similar repeat expansion mutations, with similar yet distinct clinical features. Aberrant splicing of multiple effector genes, as well as dysregulation of transcription and translation, has been suggested to underlie different aspects of the complex phenotypes in DM1 and DM2. Ca(2+) plays a central role in both muscle contraction and control of gene expression, and recent expression profiling studies have indicated major perturbations of the Ca(2+) signalling pathways in DM. Here we have further investigated the expression of genes and proteins involved in Ca(2+) metabolism in DM patients, including Ca(2+) channels and Ca(2+) binding proteins. METHODS: We used patient muscle biopsies to analyse mRNA expression and splicing of genes by microarray expression profiling and RT-PCR. We studied protein expression by immunohistochemistry and immunoblotting. RESULTS: Most of the genes studied showed mRNA up-regulation in expression profiling. When analysed by immunohistochemistry the Ca(2+) release channel ryanodine receptor was reduced in DM1 and DM2, as was calsequestrin 2, a sarcoplasmic reticulum lumen Ca(2+) storage protein. Abnormal splicing of ATP2A1 was more pronounced in DM2 than DM1. CONCLUSIONS: We observed abnormal mRNA and protein expression in DM affecting several proteins involved in Ca(2+) metabolism, with some differences between DM1 and DM2. Our protein expression studies are suggestive of a post-transcriptional defect(s) in the myotonic dystrophies.
Asunto(s)
Calcio/metabolismo , Distrofia Miotónica/genética , Distrofia Miotónica/metabolismo , Empalme Alternativo , Western Blotting , Proteínas de Unión al Calcio/genética , Proteínas de Unión al Calcio/metabolismo , ADN Complementario/biosíntesis , ADN Complementario/genética , Interpretación Estadística de Datos , Electroforesis en Gel de Poliacrilamida , Técnica del Anticuerpo Fluorescente , Humanos , Inmunohistoquímica , Análisis por Micromatrices , Microscopía Confocal , Músculo Esquelético/patología , ARN/biosíntesis , ARN/genética , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Canal Liberador de Calcio Receptor de Rianodina/genética , Canal Liberador de Calcio Receptor de Rianodina/metabolismo , ATPasas Transportadoras de Calcio del Retículo Sarcoplásmico/genéticaAsunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Metástasis de la Neoplasia/diagnóstico , Metástasis de la Neoplasia/fisiopatología , Neoplasias de la Vejiga Urinaria/complicaciones , Neoplasias de la Vejiga Urinaria , Neoplasias Óseas/complicaciones , Carcinoma/complicaciones , Carcinoma , Estudios de Cohortes , Metástasis de la Neoplasia/radioterapiaAsunto(s)
Neoplasias Óseas/secundario , Carcinoma de Células Transicionales/secundario , Neoplasias de la Vejiga Urinaria/patología , Anciano , Neoplasias Óseas/epidemiología , Carcinoma de Células Transicionales/epidemiología , Carcinoma de Células Transicionales/patología , Femenino , Humanos , Masculino , Invasividad Neoplásica , PrevalenciaRESUMEN
Introducción: Tratamos de identificar la prevalencia, presentación, tratamiento y pronóstico de la artritis aguda secundaria al tratamiento de los bacilos de Calmette-Guérin (BCG) intravesicales en el cáncer de vejiga. Métodos: Se realizó una revisión estructurada y sistemática de la literatura en lengua inglesa relacionada con BCG y artritis reactiva en pacientes con cáncer de vejiga. Se extrajeron los datos relativos a la prevalencia, presentación, manejo y pronóstico .Resultados: Se obtuvieron 23 informes de casos individuales y 4 artículos de revisión. Treinta y nueve pacientes -31 (80%) eran hombres y 8 (20%) mujeres-fueron descritos en estas publicaciones; también identificamos un paciente de nuestra institución. Aunque las estimaciones de prevalencia de la artritis reactiva oscilan entre el 0,5 y 1,0% de todos los pacientes con cáncer de vejiga que recibieron BCG, la verdadera prevalencia sigue siendo poco clara. La poliartritis (68%) y la fiebre (58%) fueron los síntomas más comunes. Entre los pacientes que presentaban dolor en las articulaciones, las rodillas (41%), los tobillos (26%) y las muñecas (19%) fueron las más afectadas. El tiempo de presentación más frecuente fue inmediatamente después de la cuarta instilación de un curso de inducción de 6 semanas (25%). La terapia inicial en el 100% de los pacientes fue la interrupción del BCG. Otros tratamientos incluyeron fármacos antiinflamatorios no esteroideos (AINE) (25%), esteroides (8%), medicamentos antituberculosos (8%) y una combinación de AINE, esteroides y medicamentos antituberculosos (20%). Conclusiones: La artritis reactiva es una complicación poco frecuente, pero potencialmente grave, del tratamiento con BCG intravesical en el cáncer de vejiga, que se presenta típicamente con poliartritis y fiebre durante la inducción. Los tratamientos más comunes incluyen la suspensión inmediata de BCG y la terapia antiinflamatoria sistémica. Se necesitan más estudios para determinar la prevalencia, la fisiopatología y el pronóstico a largo plazo (AU)
Introduction: We sought to identify the prevalence, presentation, treatment, and prognosis of acute arthritis secondary to intravesical bacilli Calmette-Guérin (BCG) therapy for bladder cancer. Methods: We performed a structured, systematic review of the English language literature pertaining to BCG and reactive arthritis among bladder cancer patients. We extracted data pertaining to prevalence, presentation, management, and prognosis. Results: We extracted 23 individual case reports and 4 review articles. Thirty-nine patients-31 (80%) male and 8 (20%) female- were described in these publications; we also identified 1 patient from our institution. Although prevalence estimates of reactive arthritis range from0.5 to 1.0% of all bladder cancer patients receiving BCG, the true prevalence remains unclear. Polyarthritis (68%) and fever (58%) were the most common presenting symptoms. Among patients presenting with joint pain, the knees (41%), ankles (26%), and wrists (19%) were most often affected. The most common time of presentation was immediately following the 4th instillation of a 6-week induction course (25%). Initial therapy in 100% of patients was discontinuation of BCG. Other therapies included non steroidal anti-inflammatory drugs (NSAIDs) (25%); steroids(8%); anti-tubercular medications (8%); and combined NSAIDs, steroids, and anti-tubercular medications (20%). Conclusions: Reactive arthritis is an infrequent but potentially severe complication of intravesical BCG for bladder cancer that typically presents with polyarthritis and fever during induction. The most common treatments include immediate discontinuation of BCG and systemic anti-inflammatory therapy. Further studies are needed to determine prevalence, pathophysiology, and long-term prognosis (AU)
Asunto(s)
Humanos , Masculino , Femenino , Mycobacterium bovis , Neoplasias de la Vejiga Urinaria/prevención & control , Neoplasias de la Vejiga Urinaria/epidemiología , Artritis Reactiva/complicaciones , Mycobacterium bovis/aislamiento & purificación , Artritis/epidemiología , Antiinflamatorios no Esteroideos/uso terapéutico , Antibióticos Antituberculosos/uso terapéutico , Artralgia , Estados Unidos/epidemiología , PronósticoRESUMEN
INTRODUCTION: We sought to identify the prevalence, presentation, treatment, and prognosis of acute arthritis secondary to intravesical bacilli Calmette-Guérin (BCG) therapy for bladder cancer. METHODS: We performed a structured, systematic review of the English language literature pertaining to BCG and reactive arthritis among bladder cancer patients. We extracted data pertaining to prevalence, presentation, management, and prognosis. RESULTS: We extracted 23 individual case reports and 4 review articles. Thirty-nine patients -31 (80%) male and 8 (20%) female- were described in these publications; we also identified 1 patient from our institution. Although prevalence estimates of reactive arthritis range from 0.5 to 1.0% of all bladder cancer patients receiving BCG, the true prevalence remains unclear. Polyarthritis (68%) and fever (58%) were the most common presenting symptoms. Among patients presenting with joint pain, the knees (41%), ankles (26%), and wrists (19%) were most often affected. The most common time of presentation was immediately following the 4th instillation of a 6-week induction course (25%). Initial therapy in 100% of patients was discontinuation of BCG. Other therapies included nonsteroidal anti-inflammatory drugs (NSAIDs) (25%); steroids (8%); anti-tubercular medications (8%); and combined NSAIDs, steroids, and anti-tubercular medications (20%). CONCLUSIONS: Reactive arthritis is an infrequent but potentially severe complication of intravesical BCG for bladder cancer that typically presents with polyarthritis and fever during induction. The most common treatments include immediate discontinuation of BCG and systemic anti-inflammatory therapy. Further studies are needed to determine prevalence, pathophysiology, and long-term prognosis.
Asunto(s)
Adyuvantes Inmunológicos/efectos adversos , Artritis Reactiva/inducido químicamente , Vacuna BCG/efectos adversos , Neoplasias de la Vejiga Urinaria/tratamiento farmacológico , Femenino , Humanos , Masculino , Neoplasias de la Vejiga Urinaria/diagnóstico , Neoplasias de la Vejiga Urinaria/terapiaRESUMEN
OBJECTIVE: Description of 8 new ANO5 mutations and significant expansion of the clinical phenotype spectrum associated with previously known and unknown mutations to improve diagnostic accuracy. METHODS: DNA samples of 101 patients in 95 kindreds at our quaternary referral center in Finland, who had undetermined limb-girdle muscular dystrophy (LGMD), calf distal myopathy, or creatine kinase (CK) elevations of more than 2,000 IU/L, were selected for ANO5 genetic evaluation, and the clinical findings of patients with mutations were retrospectively analyzed. RESULTS: A total of 25 patients with muscular dystrophy caused by 11 different recessive mutations in the ANO5 gene were identified. The vast majority of mutations, 8 of 11, proved to be previously unknown new mutations. The most frequent mutation, c.2272C>T (p.R758C), was present in 20 patients. The phenotypes associated with this and the common European mutation, c.191dupA, varied from nearly asymptomatic high hyperCKemia to severe LGMD with consistently milder phenotypes in female patients. CONCLUSIONS: Mutations in ANO5 are a frequent cause of undetermined muscular dystrophy, with both distal and proximal presentation. Other types include high hyperCKemia, myalgia, or calf hypertrophy over decades without significant weakness, especially in female patients. Mutations are distributed all over the gene, indicating that muscular dystrophy caused by ANO5 can be expected to occur in all populations.
Asunto(s)
Canales de Cloruro/genética , Distrofia Muscular de Cinturas/genética , Distrofia Muscular de Cinturas/patología , Mutación/fisiología , Adulto , Edad de Inicio , Anciano , Anoctaminas , Western Blotting , Estudios de Cohortes , Creatina Quinasa/sangre , ADN/genética , Femenino , Finlandia , Genes Recesivos , Pruebas Genéticas , Variación Genética , Genotipo , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Debilidad Muscular/etiología , Músculo Esquelético/patología , Distrofia Muscular de Cinturas/diagnóstico , Fenotipo , Reproducibilidad de los ResultadosRESUMEN
Squamous cell carcinoma of the prostate gland is very rare, constituting 0.5%-1% of all prostatic malignancies. Though it has a similar clinical presentation to prostate cancer, the tumor is more aggressive, spreading to bone, liver and lung. The median survival time is approximately 14 months. Diagnosis is exclusively by histology. Therapeutic options may include radical surgery, radiotherapy, chemotherapy, hormonal therapy or a combination of these treatments. We present a case of locally advanced squamous cell carcinoma of the prostate and comment on its management and subsequent disease related complication.
Asunto(s)
Carcinoma de Células Escamosas/complicaciones , Prostatectomía/métodos , Neoplasias de la Próstata/complicaciones , Fístula Rectal/etiología , Fístula Urinaria/etiología , Anciano , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/cirugía , Diagnóstico Diferencial , Estudios de Seguimiento , Humanos , Imagen por Resonancia Magnética , Masculino , Estadificación de Neoplasias , Neoplasias de la Próstata/diagnóstico , Neoplasias de la Próstata/cirugía , Fístula Rectal/diagnóstico , Tomografía Computarizada por Rayos X , Fístula Urinaria/diagnósticoRESUMEN
Three human leucine-rich repeats and immunoglobulin-like domains (LRIG1-3) genes and proteins have recently been characterized. LRIG1 has been shown to be a suppressor of tumor growth by counteracting the signaling of epidermal growth factor receptor (EGFR) family members, including EGFR (ERBB1). Expression of LRIG proteins seems to be of importance in the pathogenesis of astrocytic tumors. In this study, the expression of LRIG1-3 was evaluated in 51 human ependymomas by immunohistochemistry. LRIG proteins were detected in all ependymomas analyzed, however, with a pronounced heterogeneity in expression and subcellular localization. Higher cytoplasmic immunoreactivity of LRIG1 correlated with older patient age and higher LRIG1 nuclear immunoreactivity with lower WHO Grade. LRIG1 displayed a stronger immunoreactivity in the cytoplasm and nuclei in spinal ependymomas than in the posterior fossa or supratentorial ependymomas, while perinuclear LRIG3 was more highly expressed in supratentorial than in infratentorial ependymomas. The indications that expression and subcellular localization of LRIG proteins could be pathogenetically associated with specific clinicopathological features of ependymoma tumors might be of importance in the carcinogeneses and tumor progression of human ependymomas.
Asunto(s)
Neoplasias Encefálicas/patología , Ependimoma/patología , Proteínas de la Membrana/biosíntesis , Neoplasias de la Columna Vertebral/patología , Adolescente , Adulto , Factores de Edad , Anciano , Neoplasias Encefálicas/metabolismo , Núcleo Celular/metabolismo , Niño , Preescolar , Citoplasma/metabolismo , Ependimoma/metabolismo , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Lactante , Masculino , Glicoproteínas de Membrana/biosíntesis , Persona de Mediana Edad , Neoplasias de la Columna Vertebral/metabolismo , Análisis de Matrices Tisulares , Organización Mundial de la SaludRESUMEN
Based on previous reports the frequency of co-segregating recessive chloride channel (CLCN1) mutations in families with myotonic dystrophy type 2 (DM2) was suspected to be increased. We have studied the frequency of CLCN1 mutations in two separate patient and control cohorts from Germany and Finland, and for comparison in a German myotonic dystrophy type 1 (DM1) patient cohort. The frequency of heterozygous recessive chloride channel (CLCN1) mutations is disproportionally higher (5 %) in currently diagnosed DM2 patients compared to 1.6 % in the control population (p = 0.037), while the frequency in DM1 patients was the same as in the controls. Because the two genes segregate independently, the prevalence of CLCN1 mutations in the total DM2 patient population is, by definition, the same as in the control population. Our findings are, however, not based on the total DM2 population but on the currently diagnosed DM2 patients and indicate a selection bias in molecular diagnostic referrals. DM2 patients with co-segregating CLCN1 mutation have an increased likelihood to be referred for molecular diagnostic testing compared to DM2 patients without co-segregating CLCN1 mutation.
Asunto(s)
Canales de Cloruro/genética , Mutación , Distrofia Miotónica/genética , Adulto , Anciano , Femenino , Finlandia , Frecuencia de los Genes , Alemania , Humanos , Masculino , Persona de Mediana Edad , FenotipoRESUMEN
BACKGROUND: Variations of the posterior tributaries of the left renal vein (LRV) are frequently encountered during various urological and vascular procedures. This can be explained by the complex embryological and anatomical arrangements of these tributaries, as well as variations in their nomenclature. AIMS: To increase awareness of the anatomical variations of the posterior tributaries of the LRV. METHODS: Twenty-one kidneys were dissected. All anatomical variations of the posterior tributaries of the LRV were recorded. RESULTS: This study highlights lumbar tributaries are common on the left side. A single left lumbar tributary was found entering the posterior surface of the LRV in 10 out of 11 specimens. However, their drainage patterns showed varied anatomical configurations. CONCLUSION: This cadaveric study was aimed to draw attention to surgically important variations of the posterior tributaries of the LRV. Increased awareness among surgeons can considerably reduce the potential risk of vascular injuries during renal surgery.
Asunto(s)
Venas Renales/anomalías , Venas Renales/anatomía & histología , Anciano , Anciano de 80 o más Años , Cadáver , Disección , Femenino , Humanos , MasculinoRESUMEN
BACKGROUND: Multiple renal arteries are a frequently found variation in many studies. It is important to recognize such variations, as more complicated surgical and radiological procedures are developed. If this possibility is not considered, complications may arise. AIMS: To increase awareness of the presence of such anatomical arrangements and allow a proper evaluation of the renal vascular anatomy. METHODS: Variations in the renal vascular supply were observed during the dissection of an 89-year-old male Caucasian cadaver. RESULTS: Three multiple right renal arteries branched off the abdominal aorta at different levels to supply the right kidney. Their anatomical relations to the adjacent structures were also recorded. CONCLUSIONS: A significant surgical and radiological difficulty may be encountered in the presence of undiagnosed variations of the renal arteries preoperatively. In selected cases, a conventional arteriography or CT angiography can be of great help in reducing unexpected problems and improving the outcome.
Asunto(s)
Arteria Renal/anomalías , Anciano de 80 o más Años , Cadáver , Humanos , MasculinoRESUMEN
We compared the bulking and tensile strength of the Pennington modified Kessler, Cruciate and the Savage repairs in an ex vivo model. A total of 60 porcine tendons were randomised to three groups, half repaired using a core suture alone and the remainder employing a core and peripheral technique. The tendons were distracted to failure. The force required to produce a 3 mm gap, the ultimate strength, the mode of failure and bulking for each repair were assessed. We found that there was a significant increase in strength without an increase in bulk as the number of strands increased. The Cruciate repair was significantly more likely to fail by suture pullout than the Pennington modified Kessler or Savage repairs. We advise the use of the Savage repair, especially in the thumb, and a Cruciate when a Savage is not possible. The Pennington modified Kessler repair should be reserved for multiple tendon injuries.